- •Genetic factors (SNPs) are known to be associated with the risk of alcohol-related cirrhosis.
- •Our 3-SNP GRS stratified alcohol users at low-/high-risk of alcohol-related cirrhosis.
- •High GRS increased the relative risk of cirrhosis more than 3-fold in alcohol users.
- •Presence of diabetes with high GRS further increased the risk more than 10-fold.
Background & Aims
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Risk for alcoholic liver cirrhosis after an initial hospital contact with alcohol problems: a nationwide prospective cohort study.Hepatology. 2017; 65: 929-937https://doi.org/10.1002/hep.28943
- Opportunities to prevent alcoholic liver cirrhosis in high-risk populations: a systematic review with meta-analysis.Am J Gastroenterol. 2019; 114: 221-232https://doi.org/10.1038/s41395-018-0282-6
- Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Arch Gen Psychiatr. 2007; 64: 830-842https://doi.org/10.1001/archpsyc.64.7.830
- Prevalence of alcoholic fatty liver disease among adults in the United States, 2001-2016.JAMA. 2019; 321: 1723-1725https://doi.org/10.1001/jama.2019.2276
- Ascitic cirrhosis in relation to alcohol consumption.IntJEpidemiol. 1978; 7: 113-120
- Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis.Drug Alcohol Rev. 2010; 29: 437-445https://doi.org/10.1111/j.1465-3362.2009.00153.x
- Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study.J Hepatol. 2015; 62: 1061-1067https://doi.org/10.1016/j.jhep.2014.12.005
- Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis.Addiction. 1999; 94: 1551-1573
- Epidemiology of alcoholic liver disease.Progliver Dis. 1976; 5: 494-515
- Alcohol consumption and risk of liver cirrhosis: a systematic review and meta-analysis.Am J Gastroenterol. 2019; 114: 1574-1586https://doi.org/10.14309/ajg.0000000000000340
- Greater risk of ascitic cirrhosis in females in relation to alcohol consumption.IntJEpidemiol. 1984; 13: 53-57
- Does advice based on biomarkers of liver injury or non-invasive tests of liver fibrosis impact high-risk drinking behaviour: a systematic review with meta-analysis.Alcohol Alcohol. 2021; https://doi.org/10.1093/alcalc/agaa143
- Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies.BMJ. 2010; 340: c1240https://doi.org/10.1136/bmj.c1240
- Effects of age, sex, body weight, and quantity of alcohol consumption on occurrence and severity of alcoholic hepatitis.Clin Gastroenterol Hepatol. 2016; 14: 1831-1838 e3https://doi.org/10.1016/j.cgh.2016.05.041
- Impact of coffee on liver diseases: a systematic review.Liver Int. 2014; 34: 495-504https://doi.org/10.1111/liv.12304
- Obesity, diabetes, coffee, tea, and cannabis use alter risk for alcohol-related cirrhosis in 2 large cohorts of high-risk drinkers.Am J Gastroenterol. 2020; 116: 106-115https://doi.org/10.14309/ajg.0000000000000833
- A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis.Nat Genet. 2015; 47: 1443-1448https://doi.org/10.1038/ng.3417
- A protein-truncating HSD17B13 variant and protection from chronic liver disease.N Engl J Med. 2018; 378: 1096-1106https://doi.org/10.1056/NEJMoa1712191
- Variant in PNPLA3 is associated with alcoholic liver disease.Nat Genet. 2010; 42 (ng.488 [pii]): 21-23https://doi.org/10.1038/ng.488
- Genome-wide association study and meta-analysis on alcohol-related liver cirrhosis identifies novel genetic risk factors.Hepatology. 2021; 73: 1920-1931https://doi.org/10.1002/hep.31535
- Brief report: genetics of alcoholic cirrhosis-GenomALC multinational study.Alcohol Clin Exp Res. 2015; 39: 836-842https://doi.org/10.1111/acer.12693
- Next-generation genotype imputation service and methods.Nat Genet. 2016; 48: 1284-1287https://doi.org/10.1038/ng.3656
- UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.Plos Med. 2015; 12e1001779https://doi.org/10.1371/journal.pmed.1001779
- Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction Study.Gastroenterology. 2021; 160: 1620-1633.e13https://doi.org/10.1053/j.gastro.2020.12.011
- Genome-wide association study for alcohol-related cirrhosis identifies risk loci in MARC1 and HNRNPUL1.Gastroenterology. 2020; 159: 1276-1289 e7https://doi.org/10.1053/j.gastro.2020.06.014
- Combined effect of PNPLA3, TM6SF2, and HSD17B13 variants on risk of cirrhosis and hepatocellular carcinoma in the general population.Hepatology. 2020; 72: 845-856https://doi.org/10.1002/hep.31238
- PNPLA3 gene polymorphism is associated with predisposition to and severity of alcoholic liver disease.Am J Gastroenterol. 2015; 110: 846-856https://doi.org/10.1038/ajg.2015.137
- A 17-beta-hydroxysteroid dehydrogenase 13 variant protects from hepatocellular carcinoma development in alcoholic liver disease.Hepatology. 2019; 70: 231-240https://doi.org/10.1002/hep.30623
- Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis.BMC Cancer. 2019; 19: 1128https://doi.org/10.1186/s12885-019-6173-4
- Association between the PNPLA3 (rs738409 CtextgreaterG) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data.Hepatology. 2014; 59https://doi.org/10.1002/hep.26767
- Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers.Hepatology. 2020; 72: 88-102https://doi.org/10.1002/hep.30996
- Genetic predisposition similarities between NASH and ASH: identification of new therapeutic targets.JHEP Rep. 2021; 3: 100284https://doi.org/10.1016/j.jhepr.2021.100284
- Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores.J Hepatol. 2021; 74: 775-782https://doi.org/10.1016/j.jhep.2020.11.024
- A polygenic risk score to refine risk stratification and prediction for severe liver disease by clinical fibrosis scores.Clin Gastroenterol Hepatol. 2021; https://doi.org/10.1016/j.cgh.2021.05.056
- Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.Nat Med. 2020; 26: 549-557https://doi.org/10.1038/s41591-020-0800-0
All authors except first three and last two are in alphabetical order